The Medicines and Healthcare products Regulatory Agency (MHRA) announced on 13 April 2026 that a partnership with eBay has resulted in the removal of 215 listings of potentially dangerous medicines from the platform. The collaboration highlights what the regulator describes as "the benefits of private/public working" in protecting consumers from unregulated medicine sales.
What was removed
According to the MHRA, the 215 removed listings involved medicines being sold outside of regulated pharmacy channels. While the regulator has not published a full breakdown of the product categories involved, the enforcement action underscores a persistent problem: prescription-only and pharmacy-only medicines appearing on general marketplace platforms where no pharmacist oversight exists.
Under UK law, medicines are classified into three categories: General Sale List (GSL), which can be sold in any retail outlet; Pharmacy (P) medicines, which require sale under the supervision of a pharmacist; and Prescription Only Medicines (POM), which require a valid prescription. Any platform selling P or POM medicines without appropriate pharmacy registration is operating unlawfully.
Why this matters for community pharmacy
The MHRA action is a reminder that community pharmacies — both high-street and legitimate online pharmacies registered with the General Pharmaceutical Council (GPhC) — remain the only legally compliant route for patients to obtain pharmacy and prescription medicines without a GP appointment.
England currently has approximately 13,147 community pharmacies on the NHS Digital contractor register, according to PharmSee data. Every one of these is subject to GPhC inspection, maintains a responsible pharmacist on the premises during opening hours, and reports dispensing activity to the NHSBSA.
By contrast, unregulated online sellers operate without clinical oversight. Patients purchasing medicines through platforms like eBay have no guarantee that the product is genuine, stored correctly, within its expiry date, or appropriate for their medical history.
The Pharmacy First context
The significance of the MHRA action is heightened by the expansion of Pharmacy First, the NHS England service that allows community pharmacists to assess and treat seven common conditions without a GP referral. As more patients are directed to pharmacies as a first point of contact for clinical advice, the gap between regulated pharmacy services and unregulated online sales becomes more visible — and more dangerous.
Pharmacists counselling patients who present with a common condition can now assess, advise, and in many cases supply medicines directly. That clinical pathway simply does not exist on a marketplace platform.
What pharmacists can do
The MHRA encourages healthcare professionals and members of the public to report suspected illegal medicine sales. Community pharmacists are well placed to:
- Ask patients about their medicine sources during consultations, particularly where a patient presents with a medicine they did not obtain through a pharmacy or GP
- Direct patients to the GPhC register to verify whether an online pharmacy is legitimate
- Report suspicious listings to the MHRA's Yellow Card scheme
The full list of registered community pharmacies is searchable at PharmSee's pharmacy directory. Patients can also verify online pharmacies through the GPhC's internet pharmacy register.
Caveats
This article is based on the MHRA's published announcement. PharmSee has not independently verified the 215-listing figure or the specific product categories involved. The MHRA's enforcement powers are limited to UK-accessible sales; cross-border online medicine sales remain a separate regulatory challenge.